获批上市-话题@MedSci

#获批上市#

99篇内容 | 2616人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1632544, encodeId=ce4b1632544a2, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=FDA：尘埃落定！“靶向突变”的基因疗法获批上市！, objectType=article, longId=124065, objectId=3c781240654e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c781240654e, replyNumber=0, likeNumber=63, createdTime=2018-08-05, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c781240654e, moduleTitle=FDA：尘埃落定！“靶向突变”的基因疗法获批上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c781240654e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632552, encodeId=376016325524e, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=FDA警告:Keytruda和Tecentriq疗效并不优于化疗 | 杨森精神分裂症药物获批上市.., objectType=article, longId=139134, objectId=012213913486, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=012213913486, replyNumber=0, likeNumber=73, createdTime=2018-06-30, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=012213913486, moduleTitle=FDA警告:Keytruda和Tecentriq疗效并不优于化疗 | 杨森精神分裂症药物获批上市.., moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=012213913486)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632545, encodeId=a877163254502, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=拜耳肝癌治疗新药在华获批上市, objectType=article, longId=133137, objectId=8d0513313e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d0513313e3c, replyNumber=0, likeNumber=75, createdTime=2019-02-22, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d0513313e3c, moduleTitle=拜耳肝癌治疗新药在华获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d0513313e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632542, encodeId=cbc716325429a, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=全球CAR-细胞疗法获批上市，一个新时代的到来？, objectType=article, longId=112302, objectId=1335112302bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1335112302bd, replyNumber=0, likeNumber=52, createdTime=2018-06-02, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1335112302bd, moduleTitle=全球CAR-细胞疗法获批上市，一个新时代的到来？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1335112302bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632551, encodeId=696c16325510d, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=又有丙肝新药在国内获批上市了！, objectType=article, longId=138237, objectId=275d13823e9b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=275d13823e9b, replyNumber=0, likeNumber=71, createdTime=2018-06-17, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=275d13823e9b, moduleTitle=又有丙肝新药在国内获批上市了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=275d13823e9b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632549, encodeId=3c9a1632549a5, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=正大天晴重磅抗肿瘤1类新药安罗替尼获批上市！, objectType=article, longId=137899, objectId=145213e899d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=145213e899d7, replyNumber=0, likeNumber=59, createdTime=2018-05-18, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=145213e899d7, moduleTitle=正大天晴重磅抗肿瘤1类新药安罗替尼获批上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=145213e899d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632541, encodeId=ae7d16325412d, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=我国自主研发脊髓灰质炎灭活疫苗获批上市！, objectType=article, longId=111448, objectId=8d2b1114484d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d2b1114484d, replyNumber=0, likeNumber=75, createdTime=2017-11-08, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d2b1114484d, moduleTitle=我国自主研发脊髓灰质炎灭活疫苗获批上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d2b1114484d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632540, encodeId=a0a5163254048, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=四大重磅国产医疗器械新品获批上市！, objectType=article, longId=97491, objectId=62299e49104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62299e49104, replyNumber=0, likeNumber=60, createdTime=2018-03-07, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62299e49104, moduleTitle=四大重磅国产医疗器械新品获批上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62299e49104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632543, encodeId=4660163254358, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=重磅！全球第二个CAR-T疗法获批上市！, objectType=article, longId=116808, objectId=f11b1168087d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f11b1168087d, replyNumber=0, likeNumber=0, createdTime=2018-06-26, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f11b1168087d, moduleTitle=重磅！全球第二个CAR-T疗法获批上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f11b1168087d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632538, encodeId=3e091632538ac, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=治疗儿童罕见病新药雅美罗提前4年获批上市, objectType=article, longId=83401, objectId=e32f83401c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e32f83401c1, replyNumber=0, likeNumber=95, createdTime=2017-10-15, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e32f83401c1, moduleTitle=治疗儿童罕见病新药雅美罗提前4年获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e32f83401c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632537, encodeId=2687163253e37, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=新型13价肺炎球菌多糖结合疫苗--沛儿13疫苗在中国获批上市, objectType=article, longId=81710, objectId=d6b681e10c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6b681e10c2, replyNumber=0, likeNumber=71, createdTime=2017-08-26, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6b681e10c2, moduleTitle=新型13价肺炎球菌多糖结合疫苗--沛儿13疫苗在中国获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6b681e10c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632539, encodeId=e961163253905, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=NGS肿瘤基因分析软件获批上市，来自华大又一支年轻团队, objectType=article, longId=86435, objectId=42598643578, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42598643578, replyNumber=0, likeNumber=67, createdTime=2017-08-13, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42598643578, moduleTitle=NGS肿瘤基因分析软件获批上市，来自华大又一支年轻团队, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42598643578)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632535, encodeId=548216325358a, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=罗氏的PD-L1单抗获优先审评权，有望今年9月获批上市, objectType=article, longId=65151, objectId=432f65151fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=432f65151fc, replyNumber=0, likeNumber=62, createdTime=2016-07-19, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=432f65151fc, moduleTitle=罗氏的PD-L1单抗获优先审评权，有望今年9月获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=432f65151fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632536, encodeId=5c111632536c8, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=具有自主知识产权长效干扰素“派格宾”获批上市, objectType=article, longId=81059, objectId=e7f5810596c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7f5810596c, replyNumber=0, likeNumber=77, createdTime=2017-05-15, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7f5810596c, moduleTitle=具有自主知识产权长效干扰素“派格宾”获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7f5810596c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632534, encodeId=f87e163253405, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=2015获批上市新药哪些会成“重磅炸弹”？, objectType=article, longId=61814, objectId=c23961814b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c23961814b2, replyNumber=0, likeNumber=68, createdTime=2016-11-11, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c23961814b2, moduleTitle=2015获批上市新药哪些会成“重磅炸弹”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c23961814b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632533, encodeId=2c051632533dd, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=中国一天一次的抗帕金森病治疗药物获批上市, objectType=article, longId=53494, objectId=f6375349411, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6375349411, replyNumber=0, likeNumber=84, createdTime=2015-11-26, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6375349411, moduleTitle=中国一天一次的抗帕金森病治疗药物获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6375349411)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632532, encodeId=34e31632532fc, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=**肺癌全自动免疫组化伴随诊断试剂盒在华获批上市, objectType=article, longId=26579, objectId=9ab3265e951, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ab3265e951, replyNumber=0, likeNumber=90, createdTime=2014-06-05, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ab3265e951, moduleTitle=**肺癌全自动免疫组化伴随诊断试剂盒在华获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ab3265e951)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632531, encodeId=274f163253175, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=Nature：新型丙肝口服药物获批上市人类将首次战胜HCV, objectType=article, longId=26246, objectId=16012624687, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16012624687, replyNumber=0, likeNumber=74, createdTime=2014-07-24, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16012624687, moduleTitle=Nature：新型丙肝口服药物获批上市人类将首次战胜HCV, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16012624687)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632530, encodeId=716b16325306a, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=阿尔茨海默病国产新药美金刚获批上市, objectType=article, longId=22800, objectId=929d2280026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=929d2280026, replyNumber=0, likeNumber=69, createdTime=2013-12-23, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=929d2280026, moduleTitle=阿尔茨海默病国产新药美金刚获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=929d2280026)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

获批上市

2020-05-29

weiz (审核中...)

前往app查看评论内容

#获批上市#

FDA：尘埃落定！“靶向突变”的基因疗法获批上市！

2018-08-05

weiz (审核中...)

前往app查看评论内容

#获批上市#

FDA警告:Keytruda和Tecentriq疗效并不优于化疗 | 杨森精神分裂症药物获批上市..

2018-06-30

weiz (审核中...)

前往app查看评论内容

#获批上市#

拜耳肝癌治疗新药在华获批上市

2019-02-22

weiz (审核中...)

前往app查看评论内容

#获批上市#

全球CAR-细胞疗法获批上市，一个新时代的到来？

2018-06-02

weiz (审核中...)

前往app查看评论内容

#获批上市#

又有丙肝新药在国内获批上市了！

2018-06-17

weiz (审核中...)

前往app查看评论内容

#获批上市#

正大天晴重磅抗肿瘤1类新药安罗替尼获批上市！

2018-05-18

weiz (审核中...)

前往app查看评论内容

#获批上市#

我国自主研发脊髓灰质炎灭活疫苗获批上市！

2017-11-08

weiz (审核中...)

前往app查看评论内容

#获批上市#

四大重磅国产医疗器械新品获批上市！

2018-03-07

weiz (审核中...)

前往app查看评论内容

#获批上市#

重磅！全球第二个CAR-T疗法获批上市！

2018-06-26

weiz (审核中...)

前往app查看评论内容

#获批上市#

治疗儿童罕见病新药雅美罗提前4年获批上市

2017-10-15

weiz (审核中...)

前往app查看评论内容

#获批上市#

新型13价肺炎球菌多糖结合疫苗--沛儿13疫苗在中国获批上市

2017-08-26

weiz (审核中...)

前往app查看评论内容

#获批上市#

NGS肿瘤基因分析软件获批上市，来自华大又一支年轻团队

2017-08-13

weiz (审核中...)

前往app查看评论内容

#获批上市#

罗氏的PD-L1单抗获优先审评权，有望今年9月获批上市

2016-07-19

weiz (审核中...)

前往app查看评论内容

#获批上市#

具有自主知识产权长效干扰素“派格宾”获批上市

2017-05-15

weiz (审核中...)

前往app查看评论内容

#获批上市#

2015获批上市新药哪些会成“重磅炸弹”？

2016-11-11

weiz (审核中...)

前往app查看评论内容

#获批上市#

中国一天一次的抗帕金森病治疗药物获批上市

2015-11-26

weiz (审核中...)

前往app查看评论内容

#获批上市#

**肺癌全自动免疫组化伴随诊断试剂盒在华获批上市

2014-06-05

weiz (审核中...)

前往app查看评论内容

#获批上市#

Nature：新型丙肝口服药物获批上市人类将首次战胜HCV

2014-07-24

weiz (审核中...)

前往app查看评论内容

#获批上市#

阿尔茨海默病国产新药美金刚获批上市

2013-12-23

科室
- - 订阅+
  - 更多科室
工具
服务